SAB BIOTHERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 51.6% | 51.6% | 35.6% |
| FY2021 | -44.5% | -44.5% | -21.1% |
| FY2022 | -60.3% | -60.3% | -36.8% |
| FY2023 | -73.6% | -73.6% | -50.3% |
| FY2024 | -131.3% | -131.3% | -77.2% |
| FY2025 | 8.8% | 8.8% | 7.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 51.6% | 51.6% | 35.6% |
| FY2021 | -44.5% | -44.5% | -21.1% |
| FY2022 | -60.3% | -60.3% | -36.8% |
| FY2023 | -73.6% | -73.6% | -50.3% |
| FY2024 | -131.3% | -131.3% | -77.2% |
| FY2025 | 8.8% | 8.8% | 7.7% |